GnRH receptors in human breast cancer and its contiguous not-involved breast tissue

Journal of Endocrinological Investigation

Volumn 23, Issue 2, 2000, Pages 90-96

  Paradiso, Angelo ^a   Pezzetta, A ^a   Cellamare, G ^b   Schittulli, F ^b   Marzullo, F ^b   Reshkin, S J ^c  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UO di Senologia   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Breast cancer; GnRH receptor; Normal tissue; Steroid receptor

Indexed keywords

ESTROGEN RECEPTOR; GONADORELIN RECEPTOR; PROGESTERONE RECEPTOR; STEROID;

ADULT; AGED; ARTICLE; BINDING SITE; BREAST CANCER; CELL PROLIFERATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; TISSUE DISTRIBUTION;

EID: 0034067866     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343685     Document Type: Article

References (27)

1. Kaufmann M. Zoladex in treatment of premenopausal metastatic breast cancer patients. Horm. Res. 1989, 32 (Suppl. 1): 202-205.
2. Klijn J.G.M., De Jong F.H., Lamberts S.W.J., Blankenstein M.A. LHRH-agonist treatment in clinical and experimental human breast cancer. J. Steroid Biochem. 1985, 23: 867-873.
3. Nicholson R.I., Walker K.J., MeClelland R.A., Dixon A., Robertson R.I., Blamcy R.W. Zoladex plus tamoxifen versus Zoladex alone in pre and perimenopausal metastatic breast cancer. J. Steroid Biochem. Molec. Biol. 1990, 37: 989-995.
4. Fekete M., Zalatmai A., Comaru-Schally A.M., Schally A.V. Membrane receptors for peptides in experimental and human pancreatic cancers. Pancreas 1989, 4: 521-528.
5. 6)-luteinizing-hormone releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res. 1990, 50: 1841-1846.
6. Emons G., Pahwa G.S., Brack C., Sturm R., Oberheuser F., Knuppen R. Gonadotrophin-releasing-hormone binding sites in human epitelial ovarian carcinoma. Eur. J. Cancer Clin. Oncol. 1989, 25: 215-221.
7. Eidne K.A., Flanagan C.A., Harris N.S., Millar R.P. Gonadotrophin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J. Clin. Endocrinol. Metab. 1987, 64: 425-432.
8. Miller W.R., Scott W.N., Morris R., Fraser N.M., Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 1985, 313: 231-233.
9. 6)-luteinizing-hormone releasing hormone, somatostatin, epidermal grow factor and sex steroids in 500 biopsy samples of human breast cancer. J. Clin. Lab. Analysis 1989, 3: 137-147.
10. Baumann K.H., Kiesel L., Kaumann M., Bastert G., Runnebaurn B. Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Breast Cancer Res. Treat. 1993, 25: 37-46.
11. Mullen P., Bramley T., Menzies G., Miller B. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissues and in MCF-7 and MDA-MB-231 cancer cells. Eur. J. Cancer 1993, 29 A: 248-252.
12. Chatzaki E., Bax C.M.R., Eidne K.A., Anderson L., Grudzinskas J.G., Gallagher C.J. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth-factor. Cancer Res. 1996, 56: 2059-2065.
13. Bazam T., Koch Y., Hazum E., Fridkin M. Gonadotropin-releasing hormone in milk. Science 1977, 198: 300-302.
14. Harris N., Dutlow C., Eidne K.A., Dongk W., Roberts J., Millar R. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines. Cancer Res. 1991, 51: 2577-2581.
15. Duval D.L., Nelson S.E., Clay CM. The tripartite basal enhancer of the gonadotropin-releasing hormone (GnRH) receptor gene promoter regulates cell-specific expression through a novel GnRH receptor activating sequence. Mol. Endocrinol. 1997, 11: 1814-1821.
16. Reshkin S.J., Albarani V., Pezzetta A., Marinaccio M., Paradiso A. Gonadotrophin releasing hormone (GnRH) receptor and steroid receptors in human uterine leiomyoma, myometrium and endometrium. Int. J. Oncol. 1997, 11: 603-607.
17. Fisher E.R., Gregorio R.M., Fisher B. The pathology of invasive breast cancer: a syllabus derived from findings of the NSABP. Cancer 1975, 36: 1-85.
18. Piffanelli A., Pelizzola D., Giovannini G., Catozzi L., Faggioli L., Giganti M. Characterization of laboratory working standards for quality control of immunometric and radiometric estrogen receptor assays. Tumori 1989, 75: 550-556.
19. Waddel/Hill. In: J. Lab. Clin. Med. 1956, 48: 311-314.
20. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci 1949, 51: 660-672.
21. Paradiso A., Mangia A., Barletta A., Fusilli S., Marzullo F., Schittulli F., De Lena M. Heterogeneity of intratumor proliferative activity in primary breast cancer: biological and clinical aspects. Eur. J. Cancer 1995, 31A: 911-916.
22. Kakar S.S., Grizzle W.E., Neill J.D. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol. Cell. Endocrinol. 1994, 106: 146-149.
23. Kottler M.L., Starzec A., Carre M.C., Lagarde J.P., Martin A., Counis R. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int. J. Cancer 1997, 71: 595-599.
24. Eidne K.A., Flanagan C.A., Millar R.P. Gonadotropin-releasing hormone binding sites in human breast carcinoma. Science 1985, 229: 989-991.
25. 3H-GnRH method for the measurement of GnRH binding sites in human breast cancer and breast cancer cell lines. Int. J. Oncol. 1995, 7: 371-375.
26. Radovick S., Ticknor C.M., Nakayama Y., Notides A.L.C., Raham A., Weintraub B.D., Cutler G.B.Jr., Wondisford E.E. Evidence for direct estrogen regulation of the human gonadotropin releasing hormone gene. J. Clin. Invest. 1991, 88: 1649-1655.
27. Motta M. Direct antiproliferative effect of LHRH agonists on human prostatic tumor cells: possible mechanism of action. Gynecol. Endocrinol. 1999, 13 (Suppl 1): 11.